Clinical trials
Active, not recruiting Phase 2 trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 10 |
| 2024 | 14 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| Sanofi | 4 |
| GlaxoSmithKline | 3 |
| Hoffmann-La Roche | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Eli Lilly and Company | 2 |
| University of Guadalajara | 2 |
| Alumis Inc | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 7 |
| Breast Neoplasms | 5 |
| Scleroderma, Diffuse | 4 |
| Autoimmune Diseases | 3 |
| Hypertension, Pulmonary | 3 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Immune System Diseases | 3 |
| Lung Diseases, Interstitial | 3 |
| Neoplasm Metastasis | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.